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Key Clinical Message
Inflammatory bowel disease can present with extraintestinal features as the
patient’s only complaint. The erythema nodosum (EN) initially affected the
upper limbs only, reminding us that signs do not always present in a classical
fashion. The presence of EN should prompt the clinician to look for any under-
lying cause.
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A 23-year-old female presented to Accident and Emer-
gency (A and E) with a 3-day history of a painful left
elbow. It had been red and swollen following mild trauma.
She also reported 11 days of diarrhea, which had been
diagnosed as viral gastroenteritis at her GP practice follow-
ing negative stool cultures. She had a past medical history
of polycystic ovarian syndrome. She did not take any regu-
lar medication and had no significant family history.
On examination she was apyrexial. Her left elbow was
erythematous, swollen, and tender with full range of
movement. A tender erythematous lesion was also noted
at the base of her left thumb. Cardio, respiratory, and
abdominal examinations were unremarkable.
Blood tests showed raised WCC and inflammatory
markers. X-ray of elbow revealed no bony abnormality or
joint effusion. The patient was diagnosed with cellulitis
and discharged 4 days later with oral flucloxacillin.
Three days later, the same patient presented again to A
and E with diffuse joint pain. Her diarrhea was persisting,
now for 3 weeks in total. She was opening her bowels six
times per day. On examination, there were raised, tender,
erythematous patches over her wrists, elbows, and the
anterior aspect of her lower limbs bilaterally. The patient
had persistently raised inflammatory markers, with CRP
231 mg/L and platelets 670 9 106/L.
Flexible sigmoidoscopy showed a granular, erythema-
tous sigmoid colon with multiple ulcers consistent with
active Crohn’s disease, which was confirmed on histology.
On further questioning, the patient reported uninten-
tional weight loss of one stone over 3 months and noc-
turnal diarrhea. She was started on hydrocortisone and
mesalazine and responded well to a course of steroids.
Discussion
Erythema nodosum (EN) is a panniculitis, or inflamma-
tion of subcutaneous fat. It is one of the extraintestinal
manifestations of inflammatory bowel disease (IBD).
There are a number of associated skin lesions in IBD,
including pyoderma gangrenosum, aphthous stomatitis,
and perianal fissures. However EN is the most common,
reported to occur in 2–15% of Crohn’s cases [1, 2]. The
presence of EN relates to disease activity, and has a higher
incidence in Crohn’s than ulcerative colitis (UC) [3]. It is
also more prevalent in younger patients [4] and in
females in the acute stages of disease [5].
It presents as tense, erythematous nodules that become
purplish, fluctuant lesions. The lesions progress to a
bruise-like appearance before resolving after two to four
weeks. They typically occur over the shins, thighs, and
forearms [6]. EN may be accompanied by systemic symp-
toms of arthralgia and fever, particularly in adults [7].
Erythema nodosum as the presenting feature of Cro-
hn’s disease has been reported elsewhere in the literature,
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sometimes preceding the diagnosis of IBD for a number
of years [8]. In one case, a child presented solely with the
skin lesions and no bowel symptoms, but had endoscopic
features of active disease in the ascending colon and ter-
minal ileum [9].
It has been proposed that the occurrence of EN in Cro-
hn’s disease is due to a T-cell mediated response to com-
mon antigens between gut bacteria and the skin [2].
Cases of EN in IBD have been associated with positive
ANCA and HLA B27 [10] and variants of the TRAF3IP2
allele [11], suggesting that genetic factors also play a role
in determining which patients with IBD develop cutane-
ous manifestations.
While idiopathic in up to 50% of cases, EN can be due
to potentially serious underlying disease, including granu-
lomatous diseases, malignancy (lymphoma and leukemia),
and infection. EN may also be drug related (oral contra-
ceptive pill, sulfonamides, phenytoin) and can develop
during pregnancy [12]. With such a broad range of
potential causes, a useful and practical approach to cate-
gorizing the etiology is to consider each differential based
on the patient’s symptoms.
As in the case described above, diarrhea and EN should
suggest either Crohn’s disease or UC. Less commonly
(<1% of cases) it occurs in acute infections including
Campylobacter and Salmonella spp, and may, therefore,
present with diarrhea of an infectious, rather than auto-
immune, etiology [5].
For the patient with EN and respiratory symptoms, it
may be due to tuberculosis or sarcoidosis. In the latter
EN is often associated with bilateral hilar lymphadenopa-
thy on chest X-ray. This is known as L€ofgren’s syndrome
and has a good prognosis [13].
EN may also occur in Bechet’s disease, defined as a
triad of aphthous ulceration, genital ulcers, and uveitis.
Leprosy is another potential, if rare, cause of EN.
Children can develop EN, most commonly following
an acute Streptococcal throat infection [7]. It has also
been reported as the presenting factor of IBD in pediatric
patients as well as adults [14].
In all cases, inflammatory markers are usually raised,
including in idiopathic EN. Many differentials may be
excluded through thorough history taking, which should
also guide initial investigations such as chest X-ray, spu-
tum or stool cultures.
Management of EN is primarily to identify and treat
the underlying cause. In IBD the clinical course of EN
generally correlates to the activity of bowel disease. Suc-
cessful treatment of Crohn’s or UC with steroids, 5-
aminosalicylates or immunomodulatory therapy leads to
resolution of the skin lesions [2]. The successful use of
anti-TNF-a agents such as adalimumab has been reported
for EN and Crohn’s resistant to other treatments [15],
although it should be noted that a case of EN developing
subsequent to the use of infliximab has also been docu-
mented in the literature [16].
Idiopathic cases of EN are self-limiting, but are more
likely to recur. One case series reported a 62% annual
relapse rate of idiopathic lesions [12]. Patients may bene-
fit from symptomatic treatment with rest, nonsteroidal
anti-inflammatories, and topical application of potassium
iodide solution. Steroids may again be considered [6].
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